These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 2832097

  • 21. Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue.
    Bode DC, Kanter JR, Brunton LL.
    Circ Res; 1991 Apr; 68(4):1070-9. PubMed ID: 1849058
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.
    Torphy TJ, Zhou HL, Cieslinski LB.
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1195-205. PubMed ID: 1335058
    [Abstract] [Full Text] [Related]

  • 25. Selective inhibition of a high affinity type IV cyclic AMP phosphodiesterase in bovine trachealis by AH 21-132. Relevance to the spasmolytic and anti-spasmogenic actions of AH 21-132 in the intact tissue.
    Giembycz MA, Barnes PJ.
    Biochem Pharmacol; 1991 Jul 15; 42(3):663-77. PubMed ID: 1650218
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Evidence for convertible forms of soluble uterine cyclic nucleotide phosphodiesterase.
    Strada SJ, Epstein PM, Gardner EA, Thompson WJ, Stancel GM.
    Biochim Biophys Acta; 1981 Sep 15; 661(1):12-20. PubMed ID: 6271215
    [Abstract] [Full Text] [Related]

  • 28. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
    Lavan BE, Lakey T, Houslay MD.
    Biochem Pharmacol; 1989 Nov 15; 38(22):4123-36. PubMed ID: 2480793
    [Abstract] [Full Text] [Related]

  • 29. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
    Nemecek GM, Butcher RW.
    J Cyclic Nucleotide Res; 1979 Dec 15; 5(6):449-61. PubMed ID: 94064
    [Abstract] [Full Text] [Related]

  • 30. Purification of the putative hormone-sensitive cyclic AMP phosphodiesterase from rat adipose tissue using a derivative of cilostamide as a novel affinity ligand.
    Degerman E, Belfrage P, Newman AH, Rice KC, Manganiello VC.
    J Biol Chem; 1987 Apr 25; 262(12):5797-807. PubMed ID: 3032944
    [Abstract] [Full Text] [Related]

  • 31. Purification and characterization of guanosine 3',5'-monophosphate-inhibited low K(m) adenosine 3',5'-monophosphate phosphodiesterase from human placental cytosolic fractions.
    LeBon TR, Kasuya J, Paxton RJ, Belfrage P, Hockman S, Manganiello VC, Fujita Yamaguchi Y.
    Endocrinology; 1992 Jun 25; 130(6):3265-74. PubMed ID: 1317779
    [Abstract] [Full Text] [Related]

  • 32. Sarcoplasmic reticulum-associated cyclic adenosine 5'-monophosphate phosphodiesterase activity in normal and failing human hearts.
    Movsesian MA, Smith CJ, Krall J, Bristow MR, Manganiello VC.
    J Clin Invest; 1991 Jul 25; 88(1):15-9. PubMed ID: 1647414
    [Abstract] [Full Text] [Related]

  • 33. Comparison of the effects of cilostazol and milrinone on cAMP-PDE activity, intracellular cAMP and calcium in the heart.
    Shakur Y, Fong M, Hensley J, Cone J, Movsesian MA, Kambayashi J, Yoshitake M, Liu Y.
    Cardiovasc Drugs Ther; 2002 Sep 25; 16(5):417-27. PubMed ID: 12652111
    [Abstract] [Full Text] [Related]

  • 34. Selective inhibition of cyclic AMP phosphodiesterase from various human tissues by milrinone, a potent cardiac bipyridine.
    Ito M, Tanaka T, Saitoh M, Masuoka H, Nakano T, Hidaka H.
    Biochem Pharmacol; 1988 May 15; 37(10):2041-4. PubMed ID: 2837222
    [Abstract] [Full Text] [Related]

  • 35. Characterization of indolidan- and rolipram-sensitive cyclic nucleotide phosphodiesterases in canine and human cardiac microsomal fractions.
    Lugnier C, Muller B, Le Bec A, Beaudry C, Rousseau E.
    J Pharmacol Exp Ther; 1993 Jun 15; 265(3):1142-51. PubMed ID: 8389853
    [Abstract] [Full Text] [Related]

  • 36. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
    Weishaar RE, Quade MM, Schenden JA, Evans DB.
    J Cyclic Nucleotide Protein Phosphor Res; 1985 Jun 15; 10(6):551-64. PubMed ID: 3003170
    [Abstract] [Full Text] [Related]

  • 37. Biochemical mechanisms for the inotropic effect of the cardiotonic drug milrinone.
    Earl CQ, Linden J, Weglicki WB.
    J Cardiovasc Pharmacol; 1986 Jun 15; 8(4):864-72. PubMed ID: 2427830
    [Abstract] [Full Text] [Related]

  • 38. Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3.
    Huston E, Lumb S, Russell A, Catterall C, Ross AH, Steele MR, Bolger GB, Perry MJ, Owens RJ, Houslay MD.
    Biochem J; 1997 Dec 01; 328 ( Pt 2)(Pt 2):549-58. PubMed ID: 9371714
    [Abstract] [Full Text] [Related]

  • 39. Characterization of a liver low Michaelis-Menten constant 3',5'-cyclic adenosine monophosphate phosphodiesterase activity sensitive to thyroid status.
    Benelli C, Geoffroy V, Fouque F, Lopez S, Desbuquois B.
    Endocrinology; 1991 May 01; 128(5):2376-86. PubMed ID: 1850351
    [Abstract] [Full Text] [Related]

  • 40. Properties of multiple kinetic forms of soluble cyclic nucleotide phosphodiesterase activity of rat colonic mucosa.
    Craven PA, Neidig M, DeRubertis FR.
    Biochim Biophys Acta; 1983 May 18; 744(3):265-75. PubMed ID: 6303428
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.